BR0114839A - composição, e método de liberação de uma substáncia ou um material eletroprocessado em um local desejado - Google Patents
composição, e método de liberação de uma substáncia ou um material eletroprocessado em um local desejadoInfo
- Publication number
- BR0114839A BR0114839A BRPI0114839-7A BR0114839A BR0114839A BR 0114839 A BR0114839 A BR 0114839A BR 0114839 A BR0114839 A BR 0114839A BR 0114839 A BR0114839 A BR 0114839A
- Authority
- BR
- Brazil
- Prior art keywords
- substance
- electroprocessed material
- releasing
- composition
- compositions
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 8
- 239000000463 material Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 229920002994 synthetic fiber Polymers 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3847—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
- B29C41/006—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor using an electrostatic field for applying the material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C67/00—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
- B29C67/0007—Manufacturing coloured articles not otherwise provided for, e.g. by colour change
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0012—Cell encapsulation
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/56—Fibrin; Thrombin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Mechanical Engineering (AREA)
- Hematology (AREA)
- Botany (AREA)
- Manufacturing & Machinery (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Textile Engineering (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
"COMPOSIçãO, E MéTODO DE LIBERAçãO DE UMA SUBSTáNCIA OU UM MATERIAL ELETROPROCESSADO EM UM LOCAL DESEJADO". A invenção está direcionada a novas composições que compreendem um material eletroprocessado e uma substância, sua formação e uso. O material eletroprocessado pode, por exemplo, ser um ou mais materiais naturais, um ou mais materiais sintéticos, ou uma combinação deles. A substância pode ser uma ou mais substâncias terapêuticas ou cosméticas ou outros compostos, moléculas, células ou vesículas. As composições podem ser usadas em transferência da substância, incluindo a transferência da droga dentro de um organismo por meio de, por exemplo, liberar substâncias ou conter células que liberem substâncias. As composições podem ser usadas para outros propósitos, tais como próteses ou implantes similares.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24100800P | 2000-10-18 | 2000-10-18 | |
US71425500A | 2000-11-17 | 2000-11-17 | |
US27011801P | 2001-02-22 | 2001-02-22 | |
PCT/US2001/027409 WO2002018441A2 (en) | 2000-09-01 | 2001-09-04 | Electroprocessed fibrin-based matrices and tissues |
US09/946,158 US20020042128A1 (en) | 2000-09-01 | 2001-09-04 | Electroprocessed fibrin-based matrices and tissues |
PCT/US2001/032301 WO2002032397A2 (en) | 2000-10-18 | 2001-10-18 | Electroprocessing in drug delivery and cell encapsulation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0114839A true BR0114839A (pt) | 2006-11-07 |
Family
ID=27500030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0114839-7A BR0114839A (pt) | 2000-10-18 | 2001-10-18 | composição, e método de liberação de uma substáncia ou um material eletroprocessado em um local desejado |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1333808B1 (pt) |
JP (1) | JP4290980B2 (pt) |
AU (2) | AU2002224387B2 (pt) |
BR (1) | BR0114839A (pt) |
CA (1) | CA2464092C (pt) |
WO (1) | WO2002032397A2 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4485124B2 (ja) * | 2000-11-17 | 2010-06-16 | ヴァージニア コモンウェルス ユニバーシティ インテレクチュアル プロパティー ファンデーション | 電気処理されたコラーゲン |
TW200410714A (en) * | 2002-08-07 | 2004-07-01 | Smithkline Beecham Corp | Electrospun amorphous pharmaceutical compositions |
DE10237571A1 (de) * | 2002-08-13 | 2004-02-26 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Endovaskuläres Implantat mit aktiver Beschichtung |
EP1555957A4 (en) * | 2002-10-04 | 2010-11-24 | Nanomatrix Inc | CLOSURE FOR SKIN AND OTHER TISSUE |
GB0329310D0 (en) * | 2003-12-18 | 2004-01-21 | Univ Keele | Method |
US8980323B2 (en) | 2006-08-29 | 2015-03-17 | Fujifilm Corporation | Hydrophilic matrix containing poorly water-soluble compound and method for producing the same |
WO2008047857A1 (fr) * | 2006-10-18 | 2008-04-24 | Fujifilm Corporation | Procédé de production d'une composition comprenant un composé difficilement soluble dans l'eau incorporé dans une matrice hydrophile et préparation pour une utilisation externe comprenant un agent ou médicament anticancéreux ayant un coefficient de partage octanol/eau (log p) de -3,0 ou plus mais pas plus de 3,0, incorporé |
WO2008062840A1 (en) | 2006-11-21 | 2008-05-29 | Fujifilm Corporation | Method for removing organic solvent |
JPWO2008072379A1 (ja) | 2006-12-13 | 2010-03-25 | 富士フイルム株式会社 | 修飾された生体高分子の製造方法及び生体高分子の架橋方法 |
JP5497449B2 (ja) | 2007-11-28 | 2014-05-21 | 富士フイルム株式会社 | 生体高分子およびポリペプチドの化学修飾方法 |
US20110129510A1 (en) * | 2008-08-08 | 2011-06-02 | Basf Se | Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof |
US20110136669A1 (en) * | 2008-08-08 | 2011-06-09 | Basf Se | Continuous Fiber Layer Comprising an Active Substance on the Basis of Bio-Polymers, the use Thereof, and Method for the Production Thereof |
JP5295943B2 (ja) | 2008-12-26 | 2013-09-18 | 花王株式会社 | ナノファイバシート |
EP2589373B1 (en) | 2010-06-29 | 2021-03-17 | Kao Corporation | Nanofiber laminate sheet |
AU2016240392A1 (en) * | 2015-04-02 | 2017-10-19 | Genea Ip Holdings Pty Limited | Handling of biological samples |
FR3047901B1 (fr) * | 2016-02-22 | 2018-02-23 | Universite Pierre Et Marie Curie (Paris 6) | Biomateriaux composites a liberation controlee de principe actif |
CN115367235A (zh) * | 2022-10-21 | 2022-11-22 | 四川科斯特自动化设备有限公司 | 一种转盘式自动化包装机设备 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1377022A (en) * | 1971-03-01 | 1974-12-11 | Avicon Inc | Structure having a microcrystalline collagen layer and method of preparing the same |
GB1527592A (en) * | 1974-08-05 | 1978-10-04 | Ici Ltd | Wound dressing |
EP0005035B1 (en) * | 1978-04-19 | 1981-09-23 | Imperial Chemical Industries Plc | A method of preparing a tubular product by electrostatic spinning |
AU3628497A (en) * | 1996-07-23 | 1998-02-10 | Electrosols Limited | A dispensing device and method for forming material |
US20020042128A1 (en) * | 2000-09-01 | 2002-04-11 | Bowlin Gary L. | Electroprocessed fibrin-based matrices and tissues |
BR0013639A (pt) | 1999-08-31 | 2004-06-15 | Univ Virginia Commonwealth | Matriz extra celular, processo para a manufatura de uma matriz extracelular, processo para formar uma prótese vascular, implante muscular, matriz extracelular para suporte de músculo, processo de formação de um revestimento facial muscular e processo de sobreposição de camadas de céluas musculares em uma matriz extracelular |
CA2396640A1 (en) * | 2000-01-28 | 2001-08-02 | Smithkline Beecham Corporation | Electrospun pharmaceutical compositions |
CA2406862A1 (en) | 2000-04-20 | 2001-11-01 | Emory University | Native protein mimetic fibers, fiber networks and fabrics for medical use |
-
2001
- 2001-10-18 JP JP2002535635A patent/JP4290980B2/ja not_active Expired - Fee Related
- 2001-10-18 AU AU2002224387A patent/AU2002224387B2/en not_active Ceased
- 2001-10-18 WO PCT/US2001/032301 patent/WO2002032397A2/en active Application Filing
- 2001-10-18 BR BRPI0114839-7A patent/BR0114839A/pt not_active Application Discontinuation
- 2001-10-18 CA CA2464092A patent/CA2464092C/en not_active Expired - Fee Related
- 2001-10-18 EP EP01987661A patent/EP1333808B1/en not_active Expired - Lifetime
- 2001-10-18 AU AU2438702A patent/AU2438702A/xx active Pending
Also Published As
Publication number | Publication date |
---|---|
JP4290980B2 (ja) | 2009-07-08 |
AU2002224387B2 (en) | 2008-02-14 |
WO2002032397A9 (en) | 2002-10-24 |
EP1333808B1 (en) | 2012-07-25 |
CA2464092C (en) | 2013-03-12 |
WO2002032397A2 (en) | 2002-04-25 |
JP2004532802A (ja) | 2004-10-28 |
CA2464092A1 (en) | 2002-04-25 |
EP1333808A2 (en) | 2003-08-13 |
AU2438702A (en) | 2002-04-29 |
WO2002032397A8 (en) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0114839A (pt) | composição, e método de liberação de uma substáncia ou um material eletroprocessado em um local desejado | |
BR9911737A (pt) | Composto, composição farmacêutica, métodos paraa profilaxia ou tratamento de uma condiçãohiperlipidêmica, de uma condição aterosclerótica ede hipercolesterolemia, uso de um composto eprocesso para a preparação de um composto | |
AR019503A1 (es) | Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas | |
IL112778A0 (en) | Substituted heterocycles, their preparation and pharmaceutical compositions containing them | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
HUP9902553A2 (hu) | Mikrocseppekből álló propofol készítmények | |
ES2052376T3 (es) | Composicion resistente al agua para el revestimiento de las pestañas, y su procedimiento de preparacion. | |
NO971563D0 (no) | Ny anvendelse av bioaktivt silikaglass og nye sammensetninger som inneholder bioaktivt silikaglass | |
BR0315824A (pt) | Composições para cuidados pessoais com enxágue que contêm partìculas poliméricas catiÈnicas de perfume | |
BRPI0516105B8 (pt) | material de implante consistindo em fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso, material de implante consistindo em aloenxerto ou colágeno e aloenxerto, método de preparação dos mesmos, uso de fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso na preparação do referido material de implante e uso de aloenxerto ou colágeno e aloenxerto na preparação do referido material de implante | |
AR024516A1 (es) | Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica. | |
ATE267798T1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
ES2185711T3 (es) | 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos. | |
AR003989A1 (es) | Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica. | |
DE69727158D1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
ID29393A (id) | Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah | |
ES2128735T3 (es) | Composiciones farmaceuticas que comprenden un antagonista de opiaceos y de sales de calcio y su uso para el tratamiento de patologias en las que intervienen las endorfinas. | |
BRPI0416108A (pt) | formulação de substáncia ativa sólida | |
ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
DE60126433D1 (de) | Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen | |
ATE271387T1 (de) | Arzneizubereitungen enthaltend vitamin d und kalzium,ihre herstellung und therapeutische verwendung | |
PT99055A (pt) | Processo para a preparacao de novas aminas alquil-heterociclicas e de composicoes farmaceuticas que as contem | |
FR2744452B1 (fr) | Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
FR2713640B1 (fr) | Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. | |
DE69717311D1 (de) | Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA A CLASSIFICACAO DE INT. CL.: B29C 41/00, C07K 14/75, A61L 15/32, C12N 5/00, C12Q 1/02, C12N 5/06, A61K 47/02 PARA INT. CL.: C07K 14/75, B29C 41/00, A61L 15/32, C12N 5/00, C12Q 1/02, C12N 5/06, A61K 47/02. Ipc: C07K 14/75 (2009.01), B29C 41/00 (2009.01), A61L 1 |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C12N 5/00 (2006.01), A61L 15/32 (2006.01), A61L 27 |
|
B11T | Dismissal: dismissal of application maintained |